WHO ICTRP trial
Diagnostic Efficacy of Prostate Targeted, Perilesional, and Systematic Biopsy: A…
ChiCTR2600116504 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2600116504 |
|---|---|
| Public title | Diagnostic Efficacy of Prostate Targeted, Perilesional, and Systematic Biopsy: A Prospective Randomized Controlled Trial |
| Scientific title | Diagnostic Efficacy of Prostate Targeted, Perilesional, and Systematic Biopsy: A Prospective Randomized Controlled Trial |
| Primary sponsor | Northern Jiangsu People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Prostate Cancer |
| Interventions | Experimental group:In addition to targeted biopsy combined with systematic biopsy, perilesional biopsy is performed around the index lesion.;Control group:None |
| Registration date | Jan 12, 2026 |
| Target size | Experimental group:437;Control group:437 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: